15 Sept 2026, 09:49
Securities Administration—
Announcement history available from 1 August 2025
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 15 Sept 2026, 09:49 | Notification of cessation of securities - AVH | Securities Administration | — | 06027 | |
| 11 Sept 2026, 12:04 | Statement of CDIs on issue - AVH | Securities Administration | — | 06007 | |
| 10 Sept 2026, 09:19 | Notification regarding unquoted securities - AVH | Securities Administration | — | 06021 | |
| 10 Sept 2026, 09:15 | Notification regarding unquoted securities - AVH | Securities Administration | — | 06021 | |
| 9 Sept 2026, 11:20 | Notification regarding unquoted securities - AVH | Securities Administration | — | 06021 | |
| 7 Sept 2026, 15:37 | Notification of cessation of securities - AVH | Securities Administration | — | 06027 | |
| 3 Sept 2026, 08:19 | AVITA to participate in US bank investor conferences | Presentations | — | 12008, 14014 | |
| 19 Aug 2026, 08:04 | AVITA Investor Webinar Slides on PermeaDerm | Presentations | — | 03026 | |
| 19 Aug 2026, 08:01 | AVITA announces positive PermeaDerm study results | Company Update | MS | 11001, 14014 | |
| 12 Aug 2026, 11:22 | Notification regarding unquoted securities - AVH | Securities Administration | — | 06021 | |
| 10 Aug 2026, 09:50 | AVITA Medical Investor Presentation August 2026 | Presentations | — | 03026 | |
| 10 Aug 2026, 08:32 | AVITA Medical to Host Investor Webinar Briefing | Presentations | — | 14014 | |
| 10 Aug 2026, 08:24 | AVITA to participate at Canaccord Genuity Growth Conference | Company Administration | — | 12008 | |
| 7 Aug 2026, 11:41 | Statement of CDIs on issue - AVH | Securities Administration | — | 06007 | |
| 7 Aug 2026, 08:26 | AVITA 10-Q Quarterly Report for Q2 2026 | Periodic Reports | MS | 03014 | |
| 7 Aug 2026, 08:26 | Half Yearly Report | Financial Results | MS | 03004 | |
| 7 Aug 2026, 08:26 | AVITA Q2 financial results earnings presentation | Presentations | MS | 03026 | |
| 7 Aug 2026, 08:26 | AVITA Medical announces Q2 2026 financial results | Quarterly Reports | MS | 03014, 19002, 19007 | |
| 6 Aug 2026, 09:48 | Notification of cessation of securities - AVH | Securities Administration | — | 06027 | |
| 15 July 2026, 08:24 | AVITA to Announce Second Quarter 2026 Financial Results | Presentations | — | 03027, 14014 | |
| 14 July 2026, 14:29 | Statement of CDIs on issue - AVH | Securities Administration | — | 06007 | |
| 13 July 2026, 08:24 | Notification regarding unquoted securities - AVH | Securities Administration | — | 06021 | |
| 13 July 2026, 08:24 | Notification regarding unquoted securities - AVH | Securities Administration | — | 06021 | |
| 8 July 2026, 16:36 | Notification of cessation of securities - AVH | Securities Administration | — | 06027 | |
| 3 July 2026, 10:14 | Notification of cessation of securities - AVH | Securities Administration | — | 06027 | |
| 19 June 2026, 08:17 | AVITA Highlights first UK Clinical Experience with RECELL GO | Company Update | — | 11001 | |
| 11 June 2026, 10:26 | Financial Report on Form 8-K Dated 5 June 2026 | Periodic Reports | — | 03014, 06009 | |
| 11 June 2026, 10:24 | Change of Director's Interest Notice -SC JCC RM JSR MT CV JW | Director Interests | — | 02009 | |
| 11 June 2026, 10:23 | Notification regarding unquoted securities - AVH | Securities Administration | — | 06021 | |
| 11 June 2026, 10:04 | Notification regarding unquoted securities - AVH | Securities Administration | — | 06021 | |
| 4 June 2026, 10:28 | Statement of CDIs on issue - AVH | Securities Administration | — | 06007 | |
| 4 June 2026, 09:48 | 2026 ASM Board Chair Script | Letters & Addresses | — | 15002 | |
| 4 June 2026, 09:47 | Change of Director's Interest Notice - JW | Director Interests | — | 02009 | |
| 4 June 2026, 09:45 | Results of 2026 Annual Meeting of Stockholders | Meetings & Governance | — | 08003 | |
| 3 June 2026, 09:05 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 2 June 2026, 12:55 | Notification regarding unquoted securities - AVH | Securities Administration | — | 06021 | |
| 2 June 2026, 11:25 | Notification of cessation of securities - AVH | Securities Administration | — | 06027 | |
| 18 May 2026, 08:26 | AVITA AU Q1 Investor Briefing Presentation | Presentations | — | 03026 | |
| 18 May 2026, 08:25 | AVITA Medical to Host Investor Webinar Briefing | Presentations | — | 14014 | |
| 15 May 2026, 08:23 | Financial Results for Quarter Ending 31 March 2026 | Periodic Reports | MS | 03014 | |
| 15 May 2026, 08:23 | AVITA Medical Q1 2026 Earnings Presentation | Presentations | MS | 03014, 03026 | |
| 15 May 2026, 08:23 | AVITA Medical Reports First Quarter 2026 Financial Results | Presentations | MS | 03014, 14014 | |
| 7 May 2026, 09:20 | Statement of CDIs on issue - AVH | Securities Administration | — | 06007 | |
| 5 May 2026, 11:42 | Notification of cessation of securities - AVH | Securities Administration | — | 06027 | |
| 4 May 2026, 08:12 | Company Administration - Other | Company Administration | — | 12008 | |
| 1 May 2026, 08:17 | AVITA Medical Names Cary Vance as Chief Executive Officer | Presentations | MS | 12017, 12019, 14014 | |
| 30 Apr 2026, 08:11 | AVITA Secures Australia & NZ Clearance for RECELL GO | Company Update | MS | 11001 | |
| 24 Apr 2026, 08:14 | AVITA to Announce First Quarter 2026 Financial Results | Periodic Reports | — | 03027 | |
| 23 Apr 2026, 08:17 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 17 Apr 2026, 08:27 | AVITA KOL Investor Webinar Presentation on Cohealyx | Presentations | — | 03026 |